277 results
6-K
RDHL
Redhill Biopharma Ltd.
6 May 24
Current report (foreign)
7:01am
a demonstrated safety and efficacy profile, and is
well-suited to counter nuclear / chemical exposure and viral pandemic scenarios, being viral
mutation-resistant … U.S. government countermeasures programs for Acute Radiation Syndrome and Sulfur Mustard exposure, oral opaganib, has a demonstrated safety
6-K
RDHL
Redhill Biopharma Ltd.
24 Apr 24
Current report (foreign)
7:05am
. Department of Defense
The study is expected to be completed by the end of 2024
RHB-107 successfully met the primary endpoint of safety and tolerability … PROTECT study is based on review of the preclinical and early clinical data, evaluating safety, tolerability, and efficacy. Selection is also based
POS AM
RDHL
Redhill Biopharma Ltd.
18 Apr 24
Prospectus update (post-effective amendment)
7:00am
, market analysis services, safety monitoring, regulatory reporting and sales data analysis and the risk that those third parties may not perform
6-K
RDHL
Redhill Biopharma Ltd.
8 Apr 24
Current report (foreign)
9:28am
development, with demonstrated safety & efficacy profiles, well suited to counter nuclear / chemical exposure and viral pandemic scenarios, being viral … effect with remdesivir in viral inhibition. Both opaganib and RHB-107 are novel, oral, host-directed small molecule drugs, with demonstrated safety
424B5
ug5b5zmr
2 Apr 24
Prospectus supplement for primary offering
4:05pm
6-K
v81klnv9tpg5mm9bx
11 Mar 24
Current report (foreign)
7:01am
6-K
f0c2rjxrr
5 Mar 24
Current report (foreign)
7:01am
6-K
pi9jn
20 Feb 24
Current report (foreign)
7:01am
F-1
EX-10.26
hkavee mys5jyjlpj3e
9 Feb 24
Registration statement (foreign)
4:20pm
424B5
73ci3z
26 Jan 24
Prospectus supplement for primary offering
9:29am
6-K
w0sdpbud7cn3
25 Jan 24
Current report (foreign)
6:02am
6-K
m5z6myrtc6qncidcp
20 Dec 23
Current report (foreign)
8:45am
6-K
o65oq4eljihv r2rle
4 Dec 23
Current report (foreign)
7:03am
6-K
g8rlc 01r46498xb7
27 Nov 23
Current report (foreign)
7:01am
424B3
oguy3 m3y
26 Oct 23
Prospectus supplement
4:52pm
F-3/A
teth um9z9as80m
23 Oct 23
Shelf registration (foreign) (amended)
4:06pm
F-3
d8olg
13 Oct 23
Shelf registration (foreign)
8:13am
6-K
fal14d pps
3 Oct 23
Current report (foreign)
7:03am
6-K
zk91g7s z7
18 Sep 23
Current report (foreign)
7:03am